Anzeige
Mehr »
Login
Donnerstag, 25.02.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Adhoc-Meldung: Eine ganz große Überraschung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KCZ1 ISIN: CA09064N1033 Ticker-Symbol: 107 
Frankfurt
25.02.21
08:01 Uhr
0,294 Euro
-0,002
-0,68 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOASIS TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
BIOASIS TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2840,31017:25
0,2880,31216:39

Aktuelle News zur BIOASIS TECHNOLOGIES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.02.Bioasis Technologies Inc.: Bioasis Announces Shares for Debt Transaction1
BIOASIS TECHNOLOGIES Aktie jetzt für 0€ handeln
11.02.Bioasis Technologies Inc: Bioasis Tech to issue 300,000 shares for debt1
01.02.Bioasis Technologies Inc: Bioasis Technologies 400,000-share private placement3
29.01.Bioasis Technologies Inc.: Bioasis Announces $200,000 Non-Brokered Private Placement-
22.01.Bioasis Technologies Inc: Bioasis grants options to buy 510,000 shares-
22.01.Bioasis Technologies Inc.: Bioasis Announces Stock Option Grant-
10.12.20Bioasis Technologies Inc: Bioasis shareholders approve all matters at AGM1
10.12.20Bioasis Technologies Inc.: Bioasis Announces Annual General Meeting Results-
10.11.20Bioasis Technologies Inc: Bioasis urges shareholders not to attend AGM in person1
04.11.20Bioasis Technologies - Shifting gears to R&D184We are expecting a major shift in day-to-day operations for Bioasis going into the second half of FY21 (year ending February) as it transitions to developing a pathway to the clinic for xB3-001 and...
► Artikel lesen
03.11.20Bioasis Technologies Inc: Bioasis sells enzyme royalty interest to Xoma1
03.11.20Bioasis Technologies Inc.: Bioasis Announces Sale of Royalty Interest in Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group-Bioasis ...-
03.11.20Xoma acquires royalty interest in lysosomal storage disorder enzymes developed under Chiesi-Bioasis alliance2
03.11.20Bioasis Technologies Inc: Bioasis to receive $1.2M from Xoma1
03.11.20XOMA Corporation: XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group-Bioasis Strategic Alliance1
29.10.20Bioasis Technologies Inc.: Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 20201
22.10.20Bioasis Technologies Inc.: Bioasis Announces Analyst Coverage Initiated by Zacks Investment Research1
20.10.20Bioasis Technologies Inc: Bioasis Technologies receives U.S. patent for xB3 tech-
20.10.20Bioasis Technologies Inc.: Bioasis Announces Issuance of US Patent Relating to xB³ Platform Technology for The Delivery of Therapeutic Agents Across the ...-
02.07.20Bioasis Technologies - Platform licensed to Chiesi808Bioasis announced on 29 June 2020 that it had entered into an agreement with Chiesi, in which it would license its technology to bypass the blood brain barrier (BBB), the xB3 platform, for the development...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1